OBJECTIVE: Lower use of medication treatment, poorer doctor-patient communication (DPC) and depression stigma are key contributors to mental healthcare disparities among Latinos with depression. The current study investigated the relationship between these key variables and the long-term trajectory of depression in primary care among Latinos. METHOD: Participants (N=220) were Latinos presenting to primary care who screened positive for depression. A repeated measures design was used to assess participants at baseline and 6, 25 and 30 months. Repeated measures included depression (Patient Health Questionnaire-9), self-reported quality of DPC and stigma pertaining to antidepressants. Using growth curve modeling, participants' depressive symptom trajectories were examined for a 30-month period. Self-reported utilization of antidepressants, DPC and antidepressant stigma were examined as predictors of the depressive symptom trajectory. In addition, rates of depression improvement/remission and recurrence/relapse were examined. RESULTS: Improvement/remission was experienced by 69.4% of participants during a 30-month period. Among those who improved/remitted at 6 or 25 months, 63.4% maintained that improvement/remission by 30 months. The long-term trajectory of depressive symptoms demonstrated a significant positive association with antidepressant stigma and significant negative associations with use of antidepressant treatment and quality DPC. CONCLUSIONS: While relapse/recurrence is common, most Latinos in this study experienced improvement in depression over 30 months. For many, there is a considerable time to reach improvement/remission. Also, these findings confirm the significance of antidepressant underutilization, DPC and stigma in the long-term outcome of depression among Latinos in primary care. Published by Elsevier Inc.
OBJECTIVE: Lower use of medication treatment, poorer doctor-patient communication (DPC) and depression stigma are key contributors to mental healthcare disparities among Latinos with depression. The current study investigated the relationship between these key variables and the long-term trajectory of depression in primary care among Latinos. METHOD:Participants (N=220) were Latinos presenting to primary care who screened positive for depression. A repeated measures design was used to assess participants at baseline and 6, 25 and 30 months. Repeated measures included depression (Patient Health Questionnaire-9), self-reported quality of DPC and stigma pertaining to antidepressants. Using growth curve modeling, participants' depressive symptom trajectories were examined for a 30-month period. Self-reported utilization of antidepressants, DPC and antidepressant stigma were examined as predictors of the depressive symptom trajectory. In addition, rates of depression improvement/remission and recurrence/relapse were examined. RESULTS: Improvement/remission was experienced by 69.4% of participants during a 30-month period. Among those who improved/remitted at 6 or 25 months, 63.4% maintained that improvement/remission by 30 months. The long-term trajectory of depressive symptoms demonstrated a significant positive association with antidepressant stigma and significant negative associations with use of antidepressant treatment and quality DPC. CONCLUSIONS: While relapse/recurrence is common, most Latinos in this study experienced improvement in depression over 30 months. For many, there is a considerable time to reach improvement/remission. Also, these findings confirm the significance of antidepressant underutilization, DPC and stigma in the long-term outcome of depression among Latinos in primary care. Published by Elsevier Inc.
Authors: K B Wells; C Sherbourne; M Schoenbaum; N Duan; L Meredith; J Unützer; J Miranda; M F Carney; L V Rubenstein Journal: JAMA Date: 2000-01-12 Impact factor: 56.272
Authors: D A Perlick; R A Rosenheck; J F Clarkin; J A Sirey; J Salahi; E L Struening; B G Link Journal: Psychiatr Serv Date: 2001-12 Impact factor: 3.084
Authors: Lisa A Cooper; Junius J Gonzales; Joseph J Gallo; Kathryn M Rost; Lisa S Meredith; Lisa V Rubenstein; Nae-Yuh Wang; Daniel E Ford Journal: Med Care Date: 2003-04 Impact factor: 2.983
Authors: Scott A Bull; X Henry Hu; Enid M Hunkeler; Janelle Y Lee; Eileen E Ming; Leona E Markson; Bruce Fireman Journal: JAMA Date: 2002-09-18 Impact factor: 56.272
Authors: Jeanne Miranda; Naihua Duan; Cathy Sherbourne; Michael Schoenbaum; Isabel Lagomasino; Maga Jackson-Triche; Kenneth B Wells Journal: Health Serv Res Date: 2003-04 Impact factor: 3.402
Authors: Miguel Ángel Cano; Marcel A de Dios; Virmarie Correa-Fernández; Sarah Childress; Jocelyn L Abrams; Angelica M Roncancio Journal: Addict Behav Date: 2017-03-27 Impact factor: 3.913
Authors: Miguel Muñoz-Laboy; Nancy Worthington; Ashley Perry; Vincent Guilamo-Ramos; Leopoldo Cabassa; Jane Lee; Nicolette Severson Journal: J Immigr Minor Health Date: 2014-12
Authors: Bonnie L Green; Maria Rosa Watson; Stacey I Kaltman; Adriana Serrano; Nicholas Talisman; Laura Kirkpatrick; Marcela Campoli Journal: J Nerv Ment Dis Date: 2017-12 Impact factor: 2.254